Multicenter phase I studies to evaluate the safety, tolerability, and clinical response to intensive dosing with the proteasome inhibitor PR-171 in patients with relapsed or refractory hematological malignancies Meeting Abstract
| Authors: | O'Connor, O. A.; Orlowski, R. Z.; Alsina, M.; Stewart, K.; Trudel, S.; Vallone, M. K.; Woo, T. M.; Urquilla, P. R.; Molineaux, C. J.; Goy, A. |
| Abstract Title: | Multicenter phase I studies to evaluate the safety, tolerability, and clinical response to intensive dosing with the proteasome inhibitor PR-171 in patients with relapsed or refractory hematological malignancies |
| Meeting Title: | 48th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 108 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2006 Dec 9-12 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2006-11-01 |
| Start Page: | 687A |
| End Page: | 688A |
| Language: | English |
| ACCESSION: | WOS:000242440003221 |
| PROVIDER: | wos |
| PUBMED: | 17139767 |
| DOI: | 10.1182/blood.V108.11.2430.2430 |
| Notes: | --- - Meeting Abstract: 2430 - 48th Annual Meeting of the American-Society-of-Hematology - DEC 09-12, 2006 - Orlando, FL - Part 1 - "Source: Wos" |
